ID

22394

Descripción

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One; ODM derived from: https://clinicaltrials.gov/show/NCT00530348

Link

https://clinicaltrials.gov/show/NCT00530348

Palabras clave

Versiones (1)
  1. 1/6/17 1/6/17 -
Subido en

1 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00530348

Inglés

Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00530348

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
given written/signed informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
age 18 to 50 years old (inclusive) as of the date the informed consent form (icf) was signed
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of ms per updated mcdonald criteria, and cranial magnetic resonance imaging (mri) scan demonstrating white matter lesions attributable to ms within 5 years of screening
Descripción

multiple sclerosis, diagnosis criteria, mri brain

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0679228
UMLS CUI [2,1]
C0024485
UMLS CUI [2,2]
C2675929
onset of ms symptoms (as determined by a neurologist, either at screening or retrospectively) within 5 years of the date the icf was signed
Descripción

onset of symptoms, multiple sclerosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0277793
UMLS CUI [1,2]
C0026769
expanded disability status scale (edss) score 0.0 to 3.0 (inclusive) at screening
Descripción

edss

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451246
greater than or equal to (>=) 2 ms attacks (first episode or relapse) occurring in the 24 months prior to the date the icf was signed, with >=1 attack in the 12 months prior to the date the icf was signed, with objective neurological signs confirmed by a physician, nurse practitioner, or other genzyme-approved health-care provider and the objective signs could be identified retrospectively
Descripción

ms attacks, quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0856120
UMLS CUI [1,2]
C1265611
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
received prior therapy for ms other than corticosteroids, for example, alemtuzumab, interferons, intravenous immunoglobulin, glatiramer acetate, natalizumab, and mitoxantrone
Descripción

prior therapy alemtuzumab, interferons, intravenous immunoglobulin, glatiramer acetate, natalizumab, mitoxantrone

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0383429
UMLS CUI [1,3]
C0021747
UMLS CUI [1,4]
C0085297
UMLS CUI [1,5]
C0289884
UMLS CUI [1,6]
C1172734
UMLS CUI [1,7]
C0026259
UMLS CUI [2]
C0149783
exposure to azathioprine, cladribine, cyclophosphamide, cyclosporine a, methotrexate, or any other immunosuppressive agent other than systemic corticosteroid treatment
Descripción

exposure to azathioprine, cladribine, cyclophosphamide, cyclosporine a, methotrexate, or any other immunosuppressive agent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0004482
UMLS CUI [1,3]
C0092801
UMLS CUI [1,4]
C0010583
UMLS CUI [1,5]
C0010592
UMLS CUI [1,6]
C0025677
UMLS CUI [1,7]
C0021081
UMLS CUI [2]
C0149783
any progressive form of ms
Descripción

progressive ms

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0751964
UMLS CUI [1,2]
C0751965
history of malignancy (except basal skin cell carcinoma)
Descripción

history of malignancy, basal skin cell carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2735088
UMLS CUI [2]
C0007117
cd4 + , cd8 + count, b cell, or absolute neutrophil count less than (<) lower limit of normal (lln) at screening
Descripción

cd4 + , cd8 + count, b cell, or absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1277776
UMLS CUI [2]
C1277777
UMLS CUI [3]
C1303089
UMLS CUI [4]
C0948762
known bleeding disorder (for example, dysfibrinogenemia, factor ix deficiency, hemophilia, von willebrand's disease, disseminated intravascular coagulation, fibrinogen deficiency, or clotting factor deficiency)
Descripción

bleeding disorder, dysfibrinogenemia, factor ix deficiency, hemophilia, von willebrand's disease, disseminated intravascular coagulation, fibrinogen deficiency, clotting factor deficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C1260903
UMLS CUI [3]
C0008533
UMLS CUI [4]
C0019069
UMLS CUI [5]
C0042974
UMLS CUI [6]
C0012739
UMLS CUI [7]
C0553681
UMLS CUI [8]
C0272315
significant autoimmune disease including but not limited to immune cytopenias, rheumatoid arthritis, systemic lupus erythematosus, other connective tissue disorders, vasculitis, inflammatory bowel disease, severe psoriasis
Descripción

autoimmune disease, immune cytopenias, rheumatoid arthritis, systemic lupus erythematosus, connective tissue disorders, vasculitis, inflammatory bowel disease, psoriasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C3274706
UMLS CUI [3]
C0003873
UMLS CUI [4]
C0024141
UMLS CUI [5]
C0009782
UMLS CUI [6]
C0042384
UMLS CUI [7]
C0021390
UMLS CUI [8]
C0033860
presence of anti-thyroid stimulating hormone (tsh) receptor (tshr) antibodies (that is, above the lln)
Descripción

TSH receptor antibodies

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201514
active infection or at high risk for infection
Descripción

active infection or at high risk for infection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205177
UMLS CUI [2,1]
C0332167
UMLS CUI [2,2]
C0009450
Volver a la parte superior de la página

Similar models

Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00530348

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
given written/signed informed consent
boolean
C0021430 (UMLS CUI [1])
age
Item
age 18 to 50 years old (inclusive) as of the date the informed consent form (icf) was signed
boolean
C0001779 (UMLS CUI [1])
multiple sclerosis, diagnosis criteria, mri brain
Item
diagnosis of ms per updated mcdonald criteria, and cranial magnetic resonance imaging (mri) scan demonstrating white matter lesions attributable to ms within 5 years of screening
boolean
C0026769 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2,1])
C2675929 (UMLS CUI [2,2])
onset of symptoms, multiple sclerosis
Item
onset of ms symptoms (as determined by a neurologist, either at screening or retrospectively) within 5 years of the date the icf was signed
boolean
C0277793 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
edss
Item
expanded disability status scale (edss) score 0.0 to 3.0 (inclusive) at screening
boolean
C0451246 (UMLS CUI [1])
ms attacks, quantity
Item
greater than or equal to (>=) 2 ms attacks (first episode or relapse) occurring in the 24 months prior to the date the icf was signed, with >=1 attack in the 12 months prior to the date the icf was signed, with objective neurological signs confirmed by a physician, nurse practitioner, or other genzyme-approved health-care provider and the objective signs could be identified retrospectively
boolean
C0856120 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
prior therapy alemtuzumab, interferons, intravenous immunoglobulin, glatiramer acetate, natalizumab, mitoxantrone
Item
received prior therapy for ms other than corticosteroids, for example, alemtuzumab, interferons, intravenous immunoglobulin, glatiramer acetate, natalizumab, and mitoxantrone
boolean
C1514463 (UMLS CUI [1,1])
C0383429 (UMLS CUI [1,2])
C0021747 (UMLS CUI [1,3])
C0085297 (UMLS CUI [1,4])
C0289884 (UMLS CUI [1,5])
C1172734 (UMLS CUI [1,6])
C0026259 (UMLS CUI [1,7])
C0149783 (UMLS CUI [2])
exposure to azathioprine, cladribine, cyclophosphamide, cyclosporine a, methotrexate, or any other immunosuppressive agent
Item
exposure to azathioprine, cladribine, cyclophosphamide, cyclosporine a, methotrexate, or any other immunosuppressive agent other than systemic corticosteroid treatment
boolean
C0332157 (UMLS CUI [1,1])
C0004482 (UMLS CUI [1,2])
C0092801 (UMLS CUI [1,3])
C0010583 (UMLS CUI [1,4])
C0010592 (UMLS CUI [1,5])
C0025677 (UMLS CUI [1,6])
C0021081 (UMLS CUI [1,7])
C0149783 (UMLS CUI [2])
progressive ms
Item
any progressive form of ms
boolean
C0751964 (UMLS CUI [1,1])
C0751965 (UMLS CUI [1,2])
history of malignancy, basal skin cell carcinoma
Item
history of malignancy (except basal skin cell carcinoma)
boolean
C2735088 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
cd4 + , cd8 + count, b cell, or absolute neutrophil count
Item
cd4 + , cd8 + count, b cell, or absolute neutrophil count less than (<) lower limit of normal (lln) at screening
boolean
C1277776 (UMLS CUI [1])
C1277777 (UMLS CUI [2])
C1303089 (UMLS CUI [3])
C0948762 (UMLS CUI [4])
bleeding disorder, dysfibrinogenemia, factor ix deficiency, hemophilia, von willebrand's disease, disseminated intravascular coagulation, fibrinogen deficiency, clotting factor deficiency
Item
known bleeding disorder (for example, dysfibrinogenemia, factor ix deficiency, hemophilia, von willebrand's disease, disseminated intravascular coagulation, fibrinogen deficiency, or clotting factor deficiency)
boolean
C0005779 (UMLS CUI [1])
C1260903 (UMLS CUI [2])
C0008533 (UMLS CUI [3])
C0019069 (UMLS CUI [4])
C0042974 (UMLS CUI [5])
C0012739 (UMLS CUI [6])
C0553681 (UMLS CUI [7])
C0272315 (UMLS CUI [8])
autoimmune disease, immune cytopenias, rheumatoid arthritis, systemic lupus erythematosus, connective tissue disorders, vasculitis, inflammatory bowel disease, psoriasis
Item
significant autoimmune disease including but not limited to immune cytopenias, rheumatoid arthritis, systemic lupus erythematosus, other connective tissue disorders, vasculitis, inflammatory bowel disease, severe psoriasis
boolean
C0004364 (UMLS CUI [1])
C3274706 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0024141 (UMLS CUI [4])
C0009782 (UMLS CUI [5])
C0042384 (UMLS CUI [6])
C0021390 (UMLS CUI [7])
C0033860 (UMLS CUI [8])
TSH receptor antibodies
Item
presence of anti-thyroid stimulating hormone (tsh) receptor (tshr) antibodies (that is, above the lln)
boolean
C0201514 (UMLS CUI [1])
active infection or at high risk for infection
Item
active infection or at high risk for infection
boolean
C0009450 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0332167 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial